Loading company details...
Beta
Latest Form 4 (Jan 6, 2026): Fortress Biotech, Inc. (10% Owner): Grant/Award of 111,209 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Jan 6, 2026 | Fortress Biotech, Inc. | Grant/Award | 111,209 | n/a |
| Apr 2, 2025 | Fortress Biotech, Inc. | Grant/Award | 33,724 | n/a |
| Dec 3, 2024 | Neil Herskowitz | Sale | 23 | $46.00 |
| Nov 8, 2024 | Jay D. Kranzler | Sale | 61 | $136.64 |
| Oct 1, 2024 | Jay D. Kranzler | Purchase | 3 | $7.20 |
| Sep 25, 2024 | Lindsay A. Rosenwald Md. | Grant/Award | 30,000 | n/a |
| Sep 25, 2024 | Neil Herskowitz | Grant/Award | 30,000 | n/a |
| Sep 25, 2024 | Curtis Gale Oltmans | Grant/Award | 30,000 | n/a |
| Sep 25, 2024 | Alexandra MacLean, Chief Executive Officer | Grant/Award | 170,000 | n/a |
| Sep 25, 2024 | Jay D. Kranzler | Grant/Award | 30,000 | n/a |